Publications

Found 1 results
Filters: Author is T. Lertwittayapon  [Clear All Filters]
2012
T. Lertwittayapon, Tencomnao, T., and Santiyanont, R., Inhibitory effect of alternatively spliced RAGEv1 on the expression of NF-kB and TNF-α in hepatocellular carcinoma cells, vol. 11, pp. 1712-1720, 2012.
Aggarwal BB and Shishodia S (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71: 1397-1421. http://dx.doi.org/10.1016/j.bcp.2006.02.009 PMid:16563357   Ahmed N (2005). Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21. http://dx.doi.org/10.1016/j.diabres.2004.09.004 PMid:15620429   Emanuele E, D'Angelo A, Tomaino C, Binetti G, et al. (2005). Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch. Neurol. 62: 1734-1736. http://dx.doi.org/10.1001/archneur.62.11.1734 PMid:16286548   Falcone C, Emanuele E, D'Angelo A, Buzzi MP, et al. (2005). Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 25: 1032-1037. http://dx.doi.org/10.1161/01.ATV.0000160342.20342.00 PMid:15731496   Fernandez-Botran R, Crespo FA and Sun X (2002). Soluble cytokine receptors in biological therapy. Expert. Opin. Biol. Ther. 2: 585-605. http://dx.doi.org/10.1517/14712598.2.6.585 PMid:12171504   Fisker S, Hansen B, Fuglsang J, Kristensen K, et al. (2004). Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. Eur. J. Endocrinol. 150: 773-777. http://dx.doi.org/10.1530/eje.0.1500773 PMid:15191346   Geroldi D, Falcone C, Emanuele E, D'Angelo A, et al. (2005). Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J. Hypertens. 23: 1725-1729. http://dx.doi.org/10.1097/01.hjh.0000177535.45785.64 PMid:16093918   Hirata K, Takada M, Suzuki Y and Kuroda Y (2003). Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells. Hepatogastroenterology 50: 1205-1207. PMid:14571699   Hiwatashi K, Ueno S, Abeyama K, Kubo F, et al. (2008). A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann. Surg. Oncol. 15: 923-933. http://dx.doi.org/10.1245/s10434-007-9698-8 PMid:18080716 PMCid:2234441   Hofmann MA, Drury S, Fu C, Qu W, et al. (1999). RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901. http://dx.doi.org/10.1016/S0092-8674(00)80801-6   Hori O, Brett J, Slattery T, Cao R, et al. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761. PMid:7592757   Hudson BI, Carter AM, Harja E, Kalea AZ, et al. (2008). Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22: 1572-1580. http://dx.doi.org/10.1096/fj.07-9909com PMid:18089847   Kalea AZ, See F, Harja E, Arriero M, et al. (2010). Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res. 70: 5628-5638. http://dx.doi.org/10.1158/0008-5472.CAN-10-0595 PMid:20570900 PMCid:2919303   Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, et al. (2005). Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 28: 2716-2721. http://dx.doi.org/10.2337/diacare.28.11.2716 PMid:16249545   Koyama H, Shoji T, Yokoyama H, Motoyama K, et al. (2005). Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25: 2587-2593. http://dx.doi.org/10.1161/01.ATV.0000190660.32863.cd PMid:16224056   Lander HM, Tauras JM, Ogiste JS, Hori O, et al. (1997). Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272: 17810-17814. http://dx.doi.org/10.1074/jbc.272.28.17810 PMid:9211935   Neeper M, Schmidt AM, Brett J, Yan SD, et al. (1992). Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004. PMid:1378843   Neumann A, Schinzel R, Palm D, Riederer P, et al. (1999). High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett. 453: 283-287. http://dx.doi.org/10.1016/S0014-5793(99)00731-0   Pullerits R, Bokarewa M, Dahlberg L and Tarkowski A (2005). Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res. Ther. 7: R817-R824. http://dx.doi.org/10.1186/ar1749 PMid:15987483 PMCid:1175032   Rojas A and Morales MA (2004). Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 76: 715-730. http://dx.doi.org/10.1016/j.lfs.2004.09.011 PMid:15581904   Rojas A, Figueroa H and Morales E (2010). Fueling inflammation at tumor microenvironment: the role of multiligand/ RAGE axis. Carcinogenesis 31: 334-341. http://dx.doi.org/10.1093/carcin/bgp322 PMid:20028726   Schmidt AM, Yan SD, Yan SF and Stern DM (2001). The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108: 949-955. PMid:11581294 PMCid:200958   Taguchi A, Blood DC, del TG, Canet A, et al. (2000). Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360. http://dx.doi.org/10.1038/35012626 PMid:10830965   Yan SD, Schmidt AM, Anderson GM, Zhang J, et al. (1994). Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269: 9889-9897. PMid:8144582   Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, et al. (2003). Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370: 1097-1109. http://dx.doi.org/10.1042/BJ20021371 PMid:12495433 PMCid:1223244